biote Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $192.2M | $197.2M | $185.4M | $165.0M | $139.4M |
| Cost of Revenue | $54.9M | $58.1M | $57.9M | $54.6M | $48.8M |
| Gross Profit | $137.4M | $139.1M | $127.5M | $110.4M | $90.6M |
| Gross Margin | 71.5% | 70.5% | 68.8% | 66.9% | 65.0% |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | $101.8M | $107.5M | $98.8M | $171.1M | $49.1M |
| Operating Income | $35.6M | $31.6M | $28.7M | $-60.7M | $34.6M |
| Operating Margin | 18.5% | 16.0% | 15.5% | -36.8% | 24.8% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $37.6M | $1.0M | $-123.0K | $1.7M | $32.9M |
| Income Tax Expense | $6.0M | $970.0K | $2.7M | $388.0K | $286.0K |
| Net Income | $27.0M | $3.2M | $3.3M | $-969.0K | $11.1M |
| Net Margin | 14.1% | 1.6% | 1.8% | -0.6% | 8.0% |
| EPS (Basic) | $0.86 | $0.09 | $0.13 | $-0.04 | — |
| EPS (Diluted) | $0.74 | $0.09 | $0.13 | $-0.04 | — |
| Shares Outstanding (Basic) | 31.3M | 34.3M | 25.7M | 24.2M | — |
| Shares Outstanding (Diluted) | 36.7M | 34.3M | 25.7M | 24.2M | — |
| Dividends Per Share | — | — | — | — | — |